Author Bokemeyer, Carsten
-
2000 | Review
Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors. Results of an update conference based on evidence-based medicine (EBM)
Souchon, R.; Krege, S.; Schmoll, H.-J.; Albers, P.; Beyer, J.; Bokemeyer, C.& Classen, J. et al. (2000)
Strahlentherapie und Onkologie, 176(9) pp. 388-405.
Urban & Vogel. DOI: https://doi.org/10.1007/PL00002347
Details DOI PMID PMC WoS
-
2002 | Conference Abstract
Nephroprotective effect of theophylline during standard dose cisplatin chemotherapy.
Benoehr, P.; Krueth, P.; Hartmann, J. T.; Grenz, A.; Osswald, H.; Mueller, G. A. & Bokemeyer, C. (2002)
Journal of the American Society of Nephrology, 13
Philadelphia: Lippincott Williams & Wilkins.
Details WoS
-
2002 | Journal Article |
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
Kollmannsberger, C.; Rick, O.; Klaproth, H.; Kubin, T.; Sayer, H. G.; Hentrich, M. & Welslau, M. et al. (2002)
British Journal of Cancer, 87(7) pp. 729-732. DOI: https://doi.org/10.1038/sj.bjc.66000524
Details DOI PMID PMC WoS
-
2004 | Conference Paper
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
Kollmannsberger, C.; Beyer, J.; Liersch, R.; Schoeffski, P.; Metzner, B.; Rick, O. & Hartmann, J. T. et al. (2004)
Journal of Clinical Oncology, 22(1) pp. 108-114. 39th Annual Meeting of the American-Society-of-Clinical-Oncology, CHICAGO, ILLINOIS.
Alexandria: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/JCO.2004.06.068
Details DOI PMID PMC WoS
-
2005 | Conference Abstract
Amplification of the MLT/MALT1 gene occurs in high-grade non-Hodgkin's lymphomas
Penas, E. M.; Becher, C.; Lampe, W.; Hinz, K.; Zivkovic, T.; Biller, L. & Bokemeyer, C. et al. (2005)
Annals of Oncology, 16 9th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2005 | Journal Article
Nephroprotection by theophylline in patients with cisplatin chemotherapy: A randomized, single-blinded, placebo-controlled trial
Benoehr, P. ; Krueth, P.; Bokemeyer, C.; Grenz, A.; Osswald, H. & Hartmann, J. T. (2005)
Journal of the American Society of Nephrology, 16(2) pp. 452-458. DOI: https://doi.org/10.1681/ASN.2004030225
Details DOI PMID PMC WoS
-
2006 | Journal Article
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphoma
Murga Penas, E. M.; Kawadler, H.; Siebert, R.; Frank, M.; Ye, H.; Hinz, K. & Becher, C. et al. (2006)
Genes Chromosomes and Cancer, 45(9) pp. 863-873. DOI: https://doi.org/10.1002/gcc.20350
Details DOI WoS
-
2008 | Conference Abstract
Response adapted assignment of the number of chemotherapy cycles for the treatment of patients with Diffuse Large B-cell Lymphoma (DLBCL) is not justified: Results of the RICOVER-60 trial of the German high-grade non-hodgkin lymphoma study group (DSHNHL)
Schubert, J.; Ziepert, M.; Lengfelder, E.; Mohren, M.; Peter, N.; Reiser, M. & Clemens, M. et al. (2008)
Onkologie, 31
Basel: Karger.
Details WoS
-
2008 | Journal Article
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
Pfreundschuh, M.; Schubert, J.; Ziepert, M.; Schmits, R.; Mohren, M.; Lengfelder, E. & Reiser, M. et al. (2008)
The Lancet Oncology, 9(2) pp. 105-116. DOI: https://doi.org/10.1016/S1470-2045(08)70002-0
Details DOI PMID PMC WoS
-
2010 | Journal Article
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A.; Pluetschow, A.; Eich, H. T.; Lohri, A.; Doerken, B.; Borchmann, P. & Berger, B. et al. (2010)
New England Journal of Medicine, 363(7) pp. 640-652. DOI: https://doi.org/10.1056/NEJMoa1000067
Details DOI PMID PMC WoS